The Federal Competition and Consumer Protection Commission (FCCPC) is removing loan apps from its approved list after they… The post FCCPC begins delisting defaultingThe Federal Competition and Consumer Protection Commission (FCCPC) is removing loan apps from its approved list after they… The post FCCPC begins delisting defaulting

FCCPC begins delisting defaulting loan apps following January 5 registration deadline

2026/01/22 00:39
3 min read

The Federal Competition and Consumer Protection Commission (FCCPC) is removing loan apps from its approved list after they failed to meet a January 5 deadline to regularise their operations.

The consumer watchdog says the affected platforms did not complete registration under the country’s new digital lending rules, which govern online and app-based credit services.

Consequently, a number of digital lending institutions have experienced the revocation of their previously granted conditional approvals. This means these apps are no longer officially approved to offer loans in Nigeria.

Dealing with financial problems? Here are 5 instant loan apps in NigeriaDealing with financial problems? Here are 5 instant loan apps in Nigeria
FCCPC’s cleanup of Nigeria’s loan app space

FCCPC Executive Vice Chairman and CEO Tunji Bello stated that the enforcement aims to restore order and trust in digital lending, not to shut down legitimate businesses, emphasising the closure of the compliance window provided under the regulations.

At this stage, the Commission is proceeding with appropriate enforcement steps in a manner that is fair, orderly, and consistent with due process,” he said. “The objective is to promote discipline, transparency, and consumer confidence within the digital lending space, not to disrupt legitimate business activity.”

The commission says its public register of approved lenders is now updated and should serve as a guide for borrowers choosing loan apps. Bello warned users to be careful when dealing with platforms that no longer appear on the list.

FCCPC Executive Vice Chairman and CEO, Tunji Bello

“The FCCPC’s register is intended to guide the public on operators that have met the applicable regulatory requirements as of the time of publication. Consumers are advised to exercise caution when dealing with digital lenders that do not appear on the Commission’s current list of approved operators,” he said.

Also read: How digital lenders can secure FCCPC approval ahead of the January 5, 2026, deadline

In addition to delisting, the FCCPC is collaborating with app stores and payment service providers to oversee compliance within the digital lending ecosystem.

What happens next for the affected loan apps

Loan apps with temporary approval have until April 2026 to finish registering under the new regulations. Bello stated this extension allows operators to correct any missing paperwork and comply with all regulatory requirements.

The commission states that this enforcement effort is designed to protect borrowers from unfair lending practices. It also aims to ensure that businesses following the rules are not unfairly impacted by those who don’t. Bello further explained that solid regulation leads to a stable environment for consumers and companies alike.

Loan apps

As digital loans become more common in Nigeria, the FCCPC states that it will increase its monitoring of the industry. This is to guarantee that loan apps are open, just, and lawful in their operations.

The post FCCPC begins delisting defaulting loan apps following January 5 registration deadline first appeared on Technext.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26